Keyphrases
ACK1
100%
Prostate Cancer
66%
Androgen Receptor
58%
Tyrosine Kinase
55%
HOXB13
42%
TNK2
39%
Phosphorylation
38%
Castration-resistant Prostate Cancer
33%
Acetylation
25%
Androgen Production
17%
Histone H2A
17%
Tyrosine
17%
Saccharomyces Cerevisiae
15%
Gene Expression
15%
DNA Repair
15%
Prostate
13%
WEE1
13%
Epigenetic Regulators
13%
Single-stranded DNA (ssDNA)
12%
Prostate Cancer Development
12%
Terminal Deoxynucleotidyl Transferase
12%
Epigenetic Reprogramming
12%
DNA Damage
12%
Receptor Tyrosine Kinase
12%
SREBF1
11%
Synaptonemal Complex
11%
Breast Cancer Susceptibility
11%
Cyclin-dependent Kinase 4 (CDK4)
11%
Anticancer Immune Response
11%
Cell Cycle Genes
11%
Immune Suppression
11%
Epigenetics
11%
Prostate Cancer Cells
10%
Double-strand Break Repair
9%
Novel Therapeutics
9%
Androgens
9%
DNA Damage Response
9%
Transcription Factor
9%
Androgen Receptor Expression
9%
Radiotherapy
9%
In Cancer
8%
End Joining
8%
Oncogene
8%
Human Prostate
8%
Epigenetic Marks
7%
Androgen Deprivation Therapy
7%
Kinase Inhibitor
7%
Telomere
7%
Meiosis
7%
Chromatin
7%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
58%
Receptor Tyrosine Kinase
57%
Epigenetics
54%
Tyrosine Kinase
53%
Kinase
46%
Phosphotransferase
46%
HOXB13
36%
Cancer Cell
32%
Tyrosine
23%
Acetylation
21%
Histone
21%
Gene Expression
20%
Histone H2A
17%
Androgen Synthesis
17%
Saccharomyces cerevisiae
15%
DNA Repair
14%
Cell Cycle
14%
DNA Damage
14%
Homeostasis
12%
Terminal Deoxynucleotidyl Transferase
12%
Reprogramming
12%
Transcription
12%
SREBF1
11%
Synaptonemal Complex
11%
Oncogene
11%
Tumor Progression
11%
Non-Receptor Tyrosine Kinase
10%
Cell Survival
9%
T Cell
9%
Telomere
9%
Enzyme
8%
Meiosis
8%
Programmed Cell Death
8%
CDC20
7%
Hormone Receptor
7%
Demethylase
7%
Histone Gene
7%
Estrogen Receptor
7%
Phosphatidylinositol
7%
Tyrosine Phosphorylation
7%
BRD4
7%
Histone H4
7%
Bromodomain
7%
Immunity
7%
Cell Proliferation
7%
Enhancer Region
7%
Synapsis
6%
Upregulation
6%
Protein Kinases
6%
Receptor Gene
6%
Medicine and Dentistry
Prostate Cancer
46%
Androgen Receptor
33%
Protein Tyrosine Kinase
29%
Cancer Cell
22%
Breast Cancer
14%
Neoplasm
11%
Cancer Resistance
11%
Cell Cycle
11%
CDK4/6 Inhibitor
11%
Immunosuppressive Treatment
11%
Phosphotransferase
11%
Castration Resistant Prostate Cancer
10%
Cancer
9%
Metastatic Carcinoma
9%
Transcription Factors
9%
Radiation Therapy
9%
Oncogene
8%
Homeostasis
8%
Breast Tumor
7%
Clinical Study
7%
Immunotherapy
7%
Gene Expression
7%
Tamoxifen
7%
Histone Demethylase
7%
Xenograft
7%
Receptor Expression
7%
Histone
6%
Drug Resistance
6%
Cell Proliferation
6%
Homeobox
6%
Immunity
6%
Malignant Neoplasm
5%
Heat Shock Protein 22
5%
Prostate Hypertrophy
5%
Radiosensitivity
5%
Interaction Network
5%
Protein Kinases
5%
Long Untranslated RNA
5%
Pancreas Cancer
5%
Enzalutamide
5%
5 Hydroxymethylcytosine
5%
Drug Sensitivity
5%
Isocitrate Dehydrogenase 2
5%
Histone H3
5%
Prostate Cell Line
5%
Antiandrogen Therapy
5%
Diagnosis
5%
Tumour Heterogeneity
5%
Tumor Resistance
5%
Stem Cell
5%